Enzyme-blocking cream may prevent or slow growth of some common skin cancers, preclinical study reveals

A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous ...
Technology Networks

Topical Cream "Wakes Up" the Immune System To Target Skin Cancer

A topical treatment blocking the enzyme LSD1 activated immune responses in skin cells and slowed tumor growth in models of ...
The American Journal of Managed Care

PD-1, PD-L1 Agents Improve Outcomes for Cutaneous Squamous Cell Carcinoma: Todd Schlesinger, MD

Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space ...
Medscape

Skin Microbiome Changes May Affect Risk for Squamous Cell Carcinoma

Comparing metagenomic profiles of the skin microbiome in immunosuppressed patients and those at high and low risk for cutaneous squamous cell carcinoma (SCC) revealed distinct expansions in fungal and ...